Johnson & Johnson Shares Nosedive After New Asbestos Report Surfaces
The Johnson & Johnson (NYSE:JNJ) asbestos saga continues. This morning, Reuters released a “special report” documenting that the manufacturer knew that its most popular product contained asbestos. Due to this report, JNJ shares have plummeted as ... [Read]
Johnson & Johnson Baby Powder Cancer Case Cleared
Johnson & Johnson (NYSE:JNJ) has successfully persuaded a California jury to reject a woman’s claims that asbestos in the company’s well-known baby powder is what caused her to develop cancer. Johnson & Johnson’s baby powder ... [Read]
CVS Health Launches its Pilot Membership Program in Boston and Its Stock Jumps
CVS Health Corporation (NYSE:CVS), also known as CVS Pharmacy, just announced that customers in the Greater Boston area can enroll in CarePass. CarePass is CVS’s new pilot membership program that adds to its popular ExtraCare ... [Read]
Pfizer Offers Early Retirement Ahead of Layoffs Next Year
Pfizer Inc. (NYSE:PFE) has been a long-time heavy hitter in the pharmaceutical industry, but it is soon facing layoffs. According to reports by CNBC, Pfizer is offering early retirement to US workers ahead of its ... [Read]
Teva Pharmaceutical Gaining Momentum After FDA Approves EpiPen
On Thursday, the FDA approved the Teva EpiPen, a move that marks a significant blow to the company’s rival, Mylan N.V. To no surprise, the market is still riding this high on Friday, allowing the ... [Read]
23andMe Gives Customer Data to GlaxoSmithKlein
23andMe launched a DNA testing service in 2007. Since then, more than 5 million people have used the genomics service to find out about their biological inheritance. With every application, 23andMe receives information about its ... [Read]
Johnson & Johnson’s Robust Growth Signifies Potential Increase in Shareholders Returns?
Johnson & Johnson (NYSE:JNJ) continues accelerating its revenue base through innovations and portfolio diversification. Second-quarter Johnson & Johnson revenue increased at a double-digit rate year over year, driven by a stable performance from Medical Devices ... [Read]
Biogen Alzheimer’s Drug Trial Sees Positive Results, Shares Soar 20%
Biogen Alzheimer’s Drug Trial: Finding a cure for Alzheimer’s disease can look like an impossible mission, even for the most brilliant minds. What isn’t impossible, however, is offering disease-modifying therapies to those suffering from the ... [Read]
Is the Dip in Johnson & Johnson Shares Offering a Buying Opportunity?
Johnson & Johnson shares tumbled more than 17% since it hit the all-time high of $148 a share at the beginning of the year. Its share price has been under pressure over the last couple ... [Read]
Aurora Cannabis Enters Agreement With Heinrich Klenk GmbH & Co.
Vancouver-based Aurora Cannabis (TSX:ACB) has entered into an agreement, through its subsidiary Pedanios, with one of Europe’s largest medicinal plant company Heinrich Klenk GmbH & Co. KG. Heinrich Klenk, whose products are available in over 25,000 pharmacies ... [Read]